Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 15, 2012
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Event Detail

Event ID 62241
Product Type Drugs
Status Ongoing
Recalling Firm Teva Pharmaceuticals USA, Inc.
City Sellersville
State PA
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-05-18
Initial Firm Notification of
Consignee or Public		 Letter
Distribution Pattern Nationwide

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30 Lot number X05011, Exp 08/13 Class II Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint. 6,647 cartons D-1442-2012
-
-